E

Evogene Ltd
D

EVGN

1.67000
USD
0.06
(3.73%)
Market Closed
Volume
0
EPS
-3
Div Yield
-
P/E
-0
Market Cap
8,960,281
OverviewSignalsIdeasNews
Related Instruments
    A
    ADMP
    0
    (0%)
    0.000000 USD
    A
    ATOS
    -0.09000
    (-6.57%)
    1.28000 USD
    N
    NVAX
    0.12000
    (1.67%)
    7.32500 USD
    O
    OCX
    -0.06000
    (-2.14%)
    2.75000 USD
    V
    VSTM
    -0.13500
    (-3.26%)
    4.00000 USD
    More
News

Title: Evogene Ltd.

Sector: Healthcare
Industry: Biotechnology
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules and genetic elements as the core components for such products. Itholds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment followed by Industry.